GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2026)

GE HealthCare Technologies (GEHC) has 5 years of Cash from Financing Activities data on file, last reported at -$236.0 million in Q2 2026.

• Quarterly Cash from Financing Activities fell 117.34% year-over-year to -$236.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$673.0 million (down 194.52% YoY) and the FY2025 annual result came in at $617.0 million, up 207.68% from the prior year.
• Cash from Financing Activities slipped to -$236.0 million in Q2 2026, from $21.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.4 billion in Q2 2025 to a low of -$1.3 billion in Q4 2024.
• A 5-year average of -$81.7 million and a median of -$159.0 million in 2024 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 2332.43% — and 2024, when it jumped 3908.33%.
• Tracing GEHC's Cash from Financing Activities over 5 years: stood at -$37.0 million in 2022, then plunged by 2332.43% to -$900.0 million in 2023, then slumped by 41.89% to -$1.3 billion in 2024, then surged by 77.06% to -$293.0 million in 2025, then increased by 19.45% to -$236.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$236.0 million (Q2 2026), $21.0 million (Q1 2026), and -$293.0 million (Q4 2025), per Business Quant data.